Propanc Biopharma Inc (PPCB)

[DarkPool]

All references to shares of common stock, warrants, options and restricted stock units outstanding as of June 12, 2019 and the related exercise prices in this registration statement, other than in our consolidated financial statements and the notes thereto included in this registration statement, have been adjusted to reflect a proposed reverse stock split of our authorized and outstanding common stock at a reverse stock split ratio of 1-for-500 (the “Reverse Stock Split”), which is expected to occur immediately following the effective date of this registration statement, but prior to the closing of the offering described herein. The number of authorized shares of our common stock after the Reverse Stock Split shall be fixed at 100,000,000 shares, which will become effective in concurrence with the consummation of such Reverse Stock Split.